GLP-1 Agonists Market Overview: Growth Outlook, Innovative Pipeline, and Leading Competitors
The pharmaceutical industry rarely sees a therapeutic class move as quickly from niche diabetes treatment to global commercial phenomenon. That is precisely what has happened with GLP-1-based therapies, and the numbers behind the glp-1 market size across the US, EU4, UK, and Japan through 2036 reflect a franchise still in its early innings despite years…
